Rekombinanter GPIIb/IIIa (Abciximab Biosimilar) Antikörper
Reaktivität: Human
BR, FACS
Wirt: Human
Monoclonal
7E3
unconjugated
Recombinant Antibody
-
- Target
- GPIIb/IIIa (Abciximab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Blocking Reagent (BR), Flow Cytometry (FACS)
- Produktmerkmale
-
Original Species of Ab: Human
Original Format of Ab: IgG1
- Aufreinigung
- Purified antibody.
- Immunogen
- CD41 is the integrin alpha chain 2b forming a fibrinogen receptor in heterodimeric complex with beta 3.
- Klon
- 7E3
- Isotyp
- IgG1 kappa
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- GPIIb/IIIa (Abciximab Biosimilar)
- Synonyme
- BDPLT16 antikoerper, BDPLT2 antikoerper, CD41 antikoerper, CD41B antikoerper, GP2B antikoerper, GPIIb antikoerper, GT antikoerper, GTA antikoerper, HPA3 antikoerper, integrin subunit alpha 2b antikoerper, ITGA2B antikoerper
- Substanzklasse
- Biosimilar
- Hintergrund
- Integrin alpha-IIb, Integrin alpha-2b, ITGA2B, platelet glycoprotein IIb of IIb/IIIa complex
- UniProt
- P08514
-
Sie sind hier:
